CRISPR-Based TB Test Detects Infection From Tongue Swabs
The test showed 74% detection rate in tongue swabs compared to 56% with traditional testing methods that rely on difficult-to-collect sputum samples.
Category: Tuberculosis
Tuberculosis
Latest
Tuberculosis
Latest
Understanding Latent Tuberculosis Diagnosis
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Tuberculosis
Latest
Tuberculosis Diagnosis Made Easy
Tuberculosis diagnosis usually requires coughing up a sputum sample from the lungs, but another way has been found to identify the disease.
FDA Approves QuantiFeron-TB Gold Plus Test for Liaison Platforms
The test enables highly automated screening for latent tuberculosis.
Read More
Cost-Effective Tests for Lyme Disease and TBRF
IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read More
Molecular QC for Rifampicin-Resistant Mycobacterium Tuberculosis
Positive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreLophius Biosciences Closes $3.4 Million Financing Round for TB Detection Assay
The funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read MoreGNA Biosolutions Closes $13.5 Million Financing Round Backed by US and EU Consortium
Series C funding will finance further development and CE marking of the company’s first molecular point-of-care platform based on pulse-controlled amplification technology.
Read More
Roche Expands Global Access Program to Include Diagnostics for Hepatitis, Human Papillomavirus, and Tuberculosis
Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read More
Researchers Discover Causative Genetic Mutations in Patients with Familial Sarcoidosis
Study data show that the metabolic sensor mTOR contributes on the genetic level to the development of sarcoidosis.
Read More
Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
BD Launches Molecular Test for Tuberculosis
The BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read More
Advancing Tuberculosis Testing
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read More
TB Data-Sharing Platform Launches to Public
The analytic visualization tool can be used to discover, grade, and track key bacterial drug-resistance mutations.
Read More
Study Confirms Blood Test as Predictor of Tuberculosis Risk
The landmark NIH study represents a major advance in tuberculosis research.
Read MoreUSAID, Cepheid Join Forces to Battle Multidrug-Resistant Tuberculosis
Cepheid has signed a memorandum of understanding representing its intention to work with USAID to support the White House’s national action plan for combating MDR-TB.
Read More
Critical Path Institute Receives Grant 
to Accelerate Tuberculosis Diagnostics
A multiyear grant from the Bill & Melinda Gates Foundation will fund an innovative global data platform
 designed to streamline tuberculosis diagnosis and treatment.
Read More
FDA Approves Cepheid’s Rapid TB Test
Results are available to clinicians in approximately 2 hours.
Read More